Long term treatment of endometriosis associated pain (EAP) with linzagolix: efficacy and safety after 12 months of treatment

In: Fertility and Sterility · 2019 · vol. 112(3) , pp. e323 · doi:10.1016/j.fertnstert.2019.07.935 · W2975434972
article OA: bronze CC0 ⤵ 5 in-corpus citations
AI-generated summary by gemini-2.5-flash-lite, 2026-06-07

Linzagolix treatment for 12 months effectively reduced endometriosis-associated pain and improved quality of life in patients with no significant safety concerns.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (6)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK